KKKayihan Karacor

Kayihan Karacor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kayihan Karacor has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of Carvacrol on PI3K/Akt Signaling, GLUT2 and Insulin Expression in Pancreatic Tissue in a Streptozotocin-Induced Type 1 Diabetic Rat Model

    by Damla Irmak, Kayihan Karacor

    Background/Objectives: Diabetes mellitus is a major global health problem with increasing prevalence worldwide. Although the antidiabetic effects of carvacrol (CRV) have been reported, the molecular mechanisms underlying its action in pancreatic tissue remain unclear. The present study investigated the role of the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway in relation to glucose transporter 2 (GLUT2) and insulin expression in pancreatic tissue in a streptozotocin-induced type 1 diabetes mellitus rat model. Methods: Forty male Wistar albino rats were randomly divided into 5 groups: Sham, CRV, Streptozotocin (STZ), STZ + CRV 40, and STZ + CRV 20. At the beginning of the experiment, 55 mg/kg STZ was administered intraperitoneally to the diabetic groups. CRV was administered at the indicated doses for six weeks. Blood glucose levels were monitored weekly. The expression levels of PI3K, phosphorylated Akt (pAkt), and GLUT2 in pancreatic tissue were evaluated using immunohistochemical and Western blot analyses, whereas insulin expression was assessed by immunohistochemistry only. Results: Carvacrol treatment at 20 mg/kg was associated with significantly lower blood glucose levels compared with the STZ group from day 10 onward, whereas no significant difference was observed between the STZ + CRV 40 and STZ groups during the post-induction measurement period. Immunohistochemical and Western blot analyses demonstrated that PI3K, pAkt, and GLUT2 protein expression levels, which were decreased in the diabetic group, were significantly increased following 20 mg/kg carvacrol administration. Immunohistochemical analysis also showed increased insulin expression in this group. Conclusions: These findings suggest that carvacrol treatment may exert beneficial effects on glycemic control, accompanied by changes in PI3K/Akt phosphorylation-related signals and increased GLUT2 and insulin immunoreactivity in pancreatic tissue.

  • Open Access

    Anti-Apoptotic Effects of Thymoquinone in Cisplatin-Induced Testicular Injury: A Focus on Cleaved Caspase-3 Expression

    by Nurcan Sahan, Damla Irmak, Kayihan Karacor

    Aim: Cisplatin, an effective chemotherapeutic agent, has many side effects, including testicular damage that impairs spermatogenesis and may cause infertility. We aimed to eliminate or minimize the negative effects of Cisplatin on testicular tissue with Thymoquinone, which is increasingly investigated due to its biological properties. Material and Method: For this purpose, 29 Wistar albino rats were randomly divided into Control (n = 4), Sham (n = 4), Cisplatin (n = 7), Cisplatin + Thymoquinone (n = 7), and Thymoquinone (n = 7) groups. Corn oil was given to the Sham group via gavage for 10 days. The Cisplatin and Cisplatin + Thymoquinone groups received Cisplatin (1.5 mg/kg/day, intraperitoneally) on days 3, 5, and 7, while Thymoquinone (50 mg/kg/day, orally) was administered daily for 10 days to the Cisplatin + Thymoquinone and Thymoquinone groups. On day 10, testicular tissues were removed under anesthesia and processed for histological and immunohistochemical analyses using Cleaved Caspase-3 antibody.Results: A significant decrease was observed in the expression of the Cleaved Caspase-3 antibody, which indicates apoptosis, in the Cisplatin + Thymoquinone group compared to the Cisplatin group. It was determined that Thymoquinone reduced testicular damage and germ cell apoptosis caused by Cisplatin. Conclusion: These results show that Thymoquinone is effective in repairing the damage caused by Cisplatin in testicular tissue and reducing spermatid apoptosis, but it needs to be supported by new studies to be used as a chemoprotectant.

  • Open Access

    Comparison of the Effects of Hyperbaric Oxygen and Ozone Therapy on Acute Lung Injury Induced in Rats

    by Omer Batuhan Usta, Gizem Demir Senoglu, Yavuz Demiraran, Kayıhan Karacor, Sengul Cangur

    Objective While the inflammatory and physiological changes caused by acute respiratory distress syndrome (ARDS) in the lungs are well-documented, studies investigating the effects of hyperbaric oxygen (HBO) and ozone therapies remain limited. The oxygenation-enhancing, anti-inflammatory, and angiogenesis-promoting effects of HBO and ozone therapies have highlighted their potential benefits in ARDS. This study aimed to compare the effects of HBO and ozone therapies on lung injury in the treatment of ARDS. Materials and Methods Thirty-two female Wistar-Albino rats were divided into four groups: saline (Group S), cefepime (Group C), cefepime and HBO (Group HBO), and cefepime and ozone therapy (Group OT). Following intratracheal Escherichia coli injection, a five-day treatment regimen was administered. Levels of interleukin (IL)-1β, IL-6, vascular endothelial growth factor (VEGF), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), partial pressure of oxygen (PO 2 ), partial pressure of carbon dioxide (PCO 2 ), and lactate in serum and lung tissue were measured, and histopathological evaluations were conducted. Results TAS, TOS, and OSI levels were significantly higher in Group S compared to the other groups (p < 0.05). PO 2 levels were significantly elevated in Groups HBO and OT (p < 0.001). VEGF levels were significantly higher in Group OT compared to the other groups (p < 0.001). Conclusion This study suggests that ozone therapy supports angiogenesis by increasing VEGF levels, while HBO therapy improves oxygenation. Ozone therapy also has the potential to mitigate the adverse effects of hyperoxia and accelerate recovery. However, further studies are required to determine the optimal duration and dosage of treatment ARDS.

  • Open Access

    Effects of Carvacrol on PI3K/Akt Pathway, Glut2 and Insulin Expression in Pancreatic Cells in a Rat Model of Type 1 Diabetes Mellitus

    by Damla Irmak, Kayihan Karacor

    Diabetes mellitus is an important disease whose prevalence is rapidly increasing every year due to genetic predisposition, malnutrition, inactivity, and obesity. The antidiabetic properties of Carvacrol (CRV) have been demonstrated in previous studies; however, it is not known through which pathway it exerts this effect in pancreatic tissue. Therefore, in our study, we planned to demonstrate the expression changes of the PI3K/Akt pathway, Glut2, and Insulin proteins in pancreatic tissue using immunohistochemical and Western-blot methods to investigate the mechanism by which CRV achieves this effect. For this purpose, 40 Wistar albino rats were randomly divided into 5 groups: Sham, CRV, Streptozotocin (STZ), STZ+CRV 40, and STZ+CRV 20. At the beginning of the experiment, 55 mg/kg STZ was administered intraperitoneally to the diabetic groups. CRV was administered at the indicated doses for 6 weeks. As a result of the experiment, a statistically significant decrease in blood glucose levels was detected in the STZ+CRV 20 and STZ+CRV 40 groups compared to the STZ group. It was found that a 20 mg/kg dose of CRV administered to the diabetic group was more effective in reducing blood glucose levels. It was shown by immunohistochemical and Western blot examination that PI3K, pAkt, Glut2, and Insulin protein expressions, which were decreased in the diabetic group, were significantly increased by 20 mg/kg Carvacrol administration. This study concluded that Carvacrol activates the PI3K/Akt pathway in pancreatic tissue in diabetes mellitus, increases Glut2 and insulin expression, and thus has a lowering effect on blood glucose levels.


  • Open Access

    Clinical and Histopathological Effects of Isotretinoin on Neuroregeneration in Experimental Spinal Cord Injury

    by Doğan Şensoy, Ömer Polat, Güven Kılıç, Muammer Yakupoğlu, Kayihan Karacor

    Aim: Spinal cord injury is an important problem, and a fully effective treatment for it has not yet been developed. Isotretinoin is a retinoid known for its anti-inflammatory effect. The present study aimed to evaluate whether isotretinoin has a positive impact on neural tissue in post-injury damage. Material and Methods: A total of 36 rats were randomly divided into 6 groups as control, sham, and injury with 14-day 7.5 mg/kg/day, 28-day 7.5 mg/kg/day, 14-day 15 mg/kg/day, and 28-day 15 mg/kg/day isotretinoin groups. Laminectomy was performed and spinal cord injury was produced by using the clip compression technique. Neurological examination was performed on days 1, 7, 14, and 28. After the treatment period, all rats were sacrificed, and their spinal cord samples were collected for histopathological assessment. Results: Groups receiving 7.5 mg/kg/day (p=0.048) and 15 mg/kg/day (p


  • Open Access

    Hydroxytyrosol affects antioxidant Nrf2 expression in the kidneys of diabetic rats

    by Hakan Soylu, Kayıhan Karaçor

    Aim: Diabetic nephropathy is the result of oxidative stress caused by chronic hyperglycemia. Nuclear factor erythroid 2-related factor 2 (Nrf2) is an important transcription factor that responds to oxidative stress. Nrf2 relieves oxidative stress, inflammation, and fibrosis associated with diabetes in the kidneys. In this study, we investigated the effects of hydroxytyrosol, which is a polyphenolic compound with proven antioxidant activity, on Nrf2 expression in diabetic kidneys. Methods: Forty male Wistar rats were used in our study and the rats were divided into four groups as control (sterile water only), hydroxytyrosol (HT) (10mg/kg hydroxytyrosol administered intraperitoneally (ip) for 30 days), streptozotocin (STZ) (diabetes was induced by administering a single dose of 55 mg/kg streptozotocin ip), and streptozotocin + hydroxytyrosol (STZ+HT) (single dose of 55 mg/kg streptozotocin and 10 mg/kg hydroxytyrosol administered ip for 30 days). At the end of the study, Nrf2 expression in kidney tissue was evaluated by immunohistochemistry and Western blot. Results: Immunohistochemistry and Western blot findings of Nrf2 were similar. It was found that while Nrf2 expression increased significantly in the HT group compared to the control group, whereas it decreased significantly in the STZ group (p<0.001). In the STZ+HT group, Nrf2 expression was found to be significantly increased compared to the STZ group (p<0.001). Conclusions: It was found that hydroxytyrosol with known antioxidant activity increased Nrf2 expression in diabetic rats. These results suggest that hydroxytyrosol may mitigate diabetic nephropathy by Nrf2-induced reduction in oxidative stress, inflammation, and fibrosis.


  • Open Access

    Hydroxytyrosol affects antioxidant Nrf2 expression in the kidneys of diabetic rats

    by Hakan Soylu, Kayıhan Karaçor

    Aim: Diabetic nephropathy is the result of oxidative stress caused by chronic hyperglycemia. Nuclear factor erythroid 2-related factor 2 (Nrf2) is an important transcription factor that responds to oxidative stress. Nrf2 relieves oxidative stress, inflammation, and fibrosis associated with diabetes in the kidneys. In this study, we investigated the effects of hydroxytyrosol, which is a polyphenolic compound with proven antioxidant activity, on Nrf2 expression in diabetic kidneys. Methods: Forty male Wistar rats were used in our study and the rats were divided into four groups as control (sterile water only), hydroxytyrosol (HT) (10mg/kg hydroxytyrosol administered intraperitoneally (ip) for 30 days), streptozotocin (STZ) (diabetes was induced by administering a single dose of 55 mg/kg streptozotocin ip), and streptozotocin + hydroxytyrosol (STZ+HT) (single dose of 55 mg/kg streptozotocin and 10 mg/kg hydroxytyrosol administered ip for 30 days). At the end of the study, Nrf2 expression in kidney tissue was evaluated by immunohistochemistry and Western blot. Results: Immunohistochemistry and Western blot findings of Nrf2 were similar. It was found that while Nrf2 expression increased significantly in the HT group compared to the control group, whereas it decreased significantly in the STZ group (p<0.001). In the STZ+HT group, Nrf2 expression was found to be significantly increased compared to the STZ group (p<0.001). Conclusions: It was found that hydroxytyrosol with known antioxidant activity increased Nrf2 expression in diabetic rats. These results suggest that hydroxytyrosol may mitigate diabetic nephropathy by Nrf2-induced reduction in oxidative stress, inflammation, and fibrosis.


  • Open Access

    Effect of Hydroxytyrosol on Prdx6 Expression in Diabetic Rat Liver

    by Eda Nur Almali, Kayihan Karacor, Hakan Soylu

    Aim: Oxidative stress caused by hyperglycemia, which is the most important complication of diabetes mellitus, causes liver damage. Hydroxytyrosol is a polyphenolic compound abundant in olive oil that protects the liver against oxidative damage. Peroxiredoxin 6 (Prdx6) is an anti-oxidative enzyme known to exist in the liver. The aim of this study was to investigate the effect of hydroxytyrosol on Prdx6 expression in diabetes-induced liver injury. Material and Methods: Male Wistar rats were grouped into four as the control group (n=10), hydroxytyrosol group (n=10), streptozotocin group (n=10), and hydroxytyrosol+streptozotocin group (n=10). Blood glucose levels of the animals were measured after streptozotocin injection and at the end of the experiment. The general structure of the liver was examined with a hematoxylin-eosin stain. Prdx6 protein expression was determined with an immunohistochemical method. Results: In the streptozotocin+hydroxytyrosol group, blood glucose level was found to be lower when compared with the streptozotocin group (p


  • Open Access

    Abirateron ve Docetaxel Tedavileri Metastatik Prostat Kanseri Hücrelerinde Phospho-PTEN Ekspresyonunu Arttırır

    by Hakan Soylu, Kübra Aksu, İsmail Üstünel, Kayihan Karacor, Özge Beyazçi̇çek

    Aim: Prostate cancer is the second leading cause of death in cancer-related deaths in men. Docetaxel and abiraterone acetate are widely used in the treatment of castration-resistant metastatic prostate cancer. Phospho-PTEN triggers proliferation, migration, angiogenesis and survival in cells by causing oncogenic Akt hyperactivation. This study, it is aimed to investigate the effects of docetaxel and abiraterone acetate agents, which are widely used in the treatment of prostate cancer, on the expression of phospho-PTEN, which stimulates the oncogenic pathway. Material and Methods: The effects of docetaxel and abiraterone acetate on phospho-PTEN expression in androgen receptor (+) and androgen receptor (-) metastatic prostate cancer cell lines were investigated in vitro by immunofluorescence method. Results: Findings were compatible in both androgen receptor (+) and androgen receptor (-) metastatic prostate cancer cell lines. No statistically significant difference in phospho-PTEN expression was observed between the control and abiraterone acetate groups. Phospho-PTEN expression was increased statistically significant in docetaxel and abiraterone acetate+docetaxel groups compared to control. This increase was greater statistically significant in the combined group given the two agents compared to the docetaxel group. Conclusion: A significant increase in phospho-PTEN was observed in the docetaxel and combined treatment groups. The increase of Phospho-PTEN causes oncogenic Akt hyperactivation. According to this information, docetaxel and combined drug treatments may support the oncogenic pathway in cells by increasing phospho-PTEN in patients. To eliminate these effects in patients, the administration of agents that dephosphorylate PTEN or agents that will stimulate the pathways that provide dephosphorylation may increase the total survival of the patients.


  • Open Access

    Characterization of Apelin/APJ Axis Expression in Normal Testicular Tissue, Germ Cell Neoplasia in Situ, and Testicular Seminoma

    by Hakan Soylu, Betül Ünal, Kubra Aksu Istil, Kayihan Karacor, Özge Beyazçi̇çEk, İsMail Üstünel

    Aim: A testicular germ cell tumour is not observed widely, but its incidence and mortality rates have increased in recent years. One of the most common forms of this tumour is seminoma. Germ cell neoplasia in situ (GCNIS) is the precursor of seminoma. The apelin/APJ axis is increased in many cancers and is a pathway that plays an active role in angiogenesis, lymphangiogenesis, tumour growth, and migration. This study investigated the cellular distributions of apelin and APJ protein expressions in normal testicular tissue (TT), GCNIS, and seminoma.Material and Methods: Tissues from 18 patients who had undergone orchiectomy were used in this study. These tissues include areas of normal TT, GCNIS, and seminoma. Immunolocalisation of apelin and APJ were identified through the immunohistochemical method.Results: Apelin expression was significantly increased in seminoma and GCNIS compared to normal. Apelin expression were the same in GCNIS and seminoma. APJ expression was significantly increased in seminoma compared to normal and GCNIS. Normal and GCNIS APJ expressions were similar.Conclusion: Expressions of apelin and APJ proteins were significantly increased in seminoma in our study. Our findings were consistent with the results of relevant studies as increased expression of apelin/APJ has been observed in many different cancers. It can be predicted that the increase of this pathway in seminoma may support angiogenesis, lymphangiogenesis, migration, and metastasis. Therefore, the increase in mortality rates in seminoma patients may be related to apelin/APJ axis. Ultimately, the use of inhibitors of this pathway in these patients may reduce their mortality rate. New studies are needed before these inhibitors can be used clinically.